Healthcare Stocks
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 101 |  TECH Bio-Techne Corp. | 57.53 USD | +3.58% | +8.75% | +11.71% | +10.98% | 9.00 B USD | ||
| 102 |  ARWR Arrowhead Research Corporation | 63.7900 USD | -2.07% | +4.88% | +13.91% | +63.15% | 8.93 B USD | ||
| 103 |  ICLR Icon Plc | 110.37 USD | +3.33% | +0.68% | +10.44% | -23.91% | 8.91 B USD | ||
| 104 |  BTSG BrightSpring Health Services, Inc. Common Stock | 46.03 USD | +1.54% | +5.57% | +18.48% | +164.54% | 8.91 B USD | ||
| 105 |  PCVX Vaxcyte, Inc. Common Stock | 61.7500 USD | +1.43% | +3.26% | +12.09% | +45.98% | 8.89 B USD | ||
| 106 |  PRAX Praxis Precision Medicines, Inc. Common Stock | 317.00 USD | +0.27% | +2.45% | +5.15% | +933.92% | 8.83 B USD | ||
| 107 |  CRL Charles River Laboratories International, Inc. | 177.5350 USD | +1.03% | +5.95% | +12.76% | -9.81% | 8.74 B USD | ||
| 108 |  HSIC Henry Schein Inc | 75.99 USD | +0.86% | +1.97% | +0.33% | +16.46% | 8.72 B USD | ||
| 109 |  ATR AptarGroup, Inc. | 131.54 USD | +0.05% | +4.39% | +1.52% | -9.82% | 8.47 B USD | ||
| 110 |  CYTK Cytokinetics Inc. | 66.7200 USD | +2.63% | +3.04% | +9.32% | +14.84% | 8.22 B USD | ||
| 111 |  NUVL Nuvalent, Inc. Class A Common Stock | 103.6900 USD | +0.92% | -0.04% | +5.02% | +9.20% | 8.15 B USD | ||
| 112 |  HALO Halozyme Therapeutics, Inc. | 66.9800 USD | -1.24% | +6.33% | +4.09% | +0.27% | 7.90 B USD | ||
| 113 |  KRYS Krystal Biotech, Inc. Common Stock | 267.4100 USD | +3.25% | +2.37% | +6.21% | +42.90% | 7.82 B USD | ||
| 114 |  BIO Bio-Rad Laboratories, Inc.Class A | 287.5900 USD | +3.03% | +5.73% | +8.29% | -14.59% | 7.76 B USD | ||
| 115 |  MOH Molina Healthcare, Inc. | 148.7100 USD | +1.95% | +0.65% | -0.53% | -9.31% | 7.66 B USD | ||
| 116 |  IBRX ImmunityBio, Inc. Common Stock | 7.30 USD | +0.27% | +4.73% | -14.32% | +168.38% | 7.51 B USD | ||
| 117 |  KYMR Kymera Therapeutics, Inc. Common Stock | 88.5300 USD | +4.09% | +4.97% | +10.02% | +49.80% | 7.23 B USD | ||
| 118 |  GKOS Glaukos Corporation | 118.96 USD | +2.22% | +1.88% | +19.51% | +29.43% | 6.91 B USD | ||
| 119 |  RGEN Repligen Corp | 122.5900 USD | +2.07% | +4.80% | +6.30% | -26.01% | 6.91 B USD | ||
| 120 |  BLTE Belite Bio, Inc American Depositary Shares | 173.18 USD | +0.24% | +1.80% | +5.53% | +198.59% | 6.81 B USD |
Nouvelles Healthcare Stocks
Cellectis conserve sa note de surperformance grâce à sa plateforme allogénique
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW)
US stock futures climb as traders cling to de-escalation hopes, await earnings
Company News for Apr 14, 2026
Asgard Therapeutics nomme Wolfram Brugger directeur médical
Grainger nomme Fiona Muldoon au poste d’administratrice non exécutive
Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma - Slideshow (NASDAQ:ALLO) 2026-04-14
Gainers Healthcare Stocks
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
 RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Healthcare Stocks
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |